Chinook Therapeutics

Novartis, Versant hope to repeat Chinook’s success by arming kidney biotech Borealis with $150M
Fierce Biotech
Thu, 08/22/24 - 11:18 am
Novartis
Chinook Therapeutics
kidney disease
venture capital
Versant Ventures
Atrasentan data backs up Novartis’ $3.5bn Chinook deal
Pharmaphorum
Mon, 10/30/23 - 10:21 am
Novartis
IgA nephropathy
atrasentan
Chinook Therapeutics
Chinook reports data from Phase I trial of CHK-336
Clinical Trials Arena
Mon, 06/19/23 - 10:26 am
Chinook Therapeutics
CHK-336
clinical trials
Biotech M&A is picking back up - here are the latest deals
BioPharma Dive
Tue, 06/13/23 - 11:37 am
Novartis
Chinook Therapeutics
Paratek
Sobi
CTI BioPharma
Astellas
Iveric Bio
Assertio Holdings
Spectrum Pharmaceuticals
Merck
Prometheus Biosciences
Pfizer
Seagen
Sanofi
Provention Bio
Sun Pharma
Concert Pharmaceuticals
BioNTech
InstaDeep
AstraXeneca
CinCor Pharma
Ipsen
Albireo
Chiesi
Amryt
Moderna Therapeutics
OriCiro Genomics
Hope springs for April inhibition
EP Vantage
Tue, 06/13/23 - 10:27 am
Novartis
Chinook Therapeutics
April inhibition
M&A
Vera Therapeutics
Otsuka
RemeGen
Alpine Immune Sciences
Akso Biopharmaceutical
Aurinia Pharmaceuticals
Novartis to acquire kidney disease biotech Chinook for up to $3.5B
BioPharma Dive
Mon, 06/12/23 - 10:24 am
Novartis
Chinook Therapeutics
M&A
kidney disease
Chinook raises $106M in private placement as it prepares to close merger with Aduro
Endpoints
Tue, 08/18/20 - 11:09 am
Chinook Therapeutics
Aduro BioTech
M&A
Chinook, Aduro Merger Plan Sets Up New Kidney Disease-Focused Biotech
Xconomy
Tue, 06/2/20 - 11:09 pm
Chinook Therapeutics
Aduro BioTech
M&A
kidney disease
New BC Biotech Chinook Reels in $65M to Tackle Kidney Disease
Xconomy
Fri, 08/23/19 - 09:48 am
Chinook Therapeutics
chronic kidney disease